Click for best price
Ulcerative Colitis Disease Treatment Drug Market Size, Share 2024
The global Ulcerative Colitis Disease Treatment Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Antibiotics Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Ulcerative Colitis Disease Treatment Drug include Abbvie Inc., Bristol Myers Squibb, Roche, Johnson & Johnson, Pfizer Inc., Prometheus Laboratories Inc. (Nestle), Bausch Health, Takeda Pharmaceutical Ltd and Biogen, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Ulcerative colitis is?a long-term condition where the colon and rectum become inflamed. The colon is the large intestine (bowel) and the rectum is the end of the bowel where poo is stored. Small ulcers can develop on the colon's lining, and can bleed and produce pus.
This report aims to provide a comprehensive presentation of the global market for Ulcerative Colitis Disease Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ulcerative Colitis Disease Treatment Drug. This report contains market size and forecasts of Ulcerative Colitis Disease Treatment Drug in global, including the following market information:
Global Ulcerative Colitis Disease Treatment Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Ulcerative Colitis Disease Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ulcerative Colitis Disease Treatment Drug Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Ulcerative Colitis Disease Treatment Drug Market Segment Percentages, by Type, 2023 (%)
Antibiotics
Amino Salicylates
Corticosteroids
Immunomodulators
Others
Global Ulcerative Colitis Disease Treatment Drug Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Ulcerative Colitis Disease Treatment Drug Market Segment Percentages, by Application, 2023 (%)
Hospitals
Specialty Clinics
Other
Global Ulcerative Colitis Disease Treatment Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Ulcerative Colitis Disease Treatment Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ulcerative Colitis Disease Treatment Drug revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Ulcerative Colitis Disease Treatment Drug revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie Inc.
Bristol Myers Squibb
Roche
Johnson & Johnson
Pfizer Inc.
Prometheus Laboratories Inc. (Nestle)
Bausch Health
Takeda Pharmaceutical Ltd
Biogen
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ulcerative Colitis Disease Treatment Drug, market overview.
Chapter 2: Global Ulcerative Colitis Disease Treatment Drug market size in revenue.
Chapter 3: Detailed analysis of Ulcerative Colitis Disease Treatment Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ulcerative Colitis Disease Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Ulcerative Colitis Disease Treatment Drug Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ulcerative Colitis Disease Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ulcerative Colitis Disease Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ulcerative Colitis Disease Treatment Drug Overall Market Size
2.1 Global Ulcerative Colitis Disease Treatment Drug Market Size: 2023 VS 2030
2.2 Global Ulcerative Colitis Disease Treatment Drug Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ulcerative Colitis Disease Treatment Drug Players in Global Market
3.2 Top Global Ulcerative Colitis Disease Treatment Drug Companies Ranked by Revenue
3.3 Global Ulcerative Colitis Disease Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Ulcerative Colitis Disease Treatment Drug Companies in Global Market, by Revenue in 2023
3.5 Global Companies Ulcerative Colitis Disease Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ulcerative Colitis Disease Treatment Drug Players in Global Market
3.6.1 List of Global Tier 1 Ulcerative Colitis Disease Treatment Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Ulcerative Colitis Disease Treatment Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ulcerative Colitis Disease Treatment Drug Market Size Markets, 2023 & 2030
4.1.2 Antibiotics
4.1.3 Amino Salicylates
4.1.4 Corticosteroids
4.1.5 Immunomodulators
4.1.6 Others
4.2 By Type - Global Ulcerative Colitis Disease Treatment Drug Revenue & Forecasts
4.2.1 By Type - Global Ulcerative Colitis Disease Treatment Drug Revenue, 2019-2024
4.2.2 By Type - Global Ulcerative Colitis Disease Treatment Drug Revenue, 2025-2030
4.2.3 By Type - Global Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ulcerative Colitis Disease Treatment Drug Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Other
5.2 By Application - Global Ulcerative Colitis Disease Treatment Drug Revenue & Forecasts
5.2.1 By Application - Global Ulcerative Colitis Disease Treatment Drug Revenue, 2019-2024
5.2.2 By Application - Global Ulcerative Colitis Disease Treatment Drug Revenue, 2025-2030
5.2.3 By Application - Global Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Ulcerative Colitis Disease Treatment Drug Market Size, 2023 & 2030
6.2 By Region - Global Ulcerative Colitis Disease Treatment Drug Revenue & Forecasts
6.2.1 By Region - Global Ulcerative Colitis Disease Treatment Drug Revenue, 2019-2024
6.2.2 By Region - Global Ulcerative Colitis Disease Treatment Drug Revenue, 2025-2030
6.2.3 By Region - Global Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Ulcerative Colitis Disease Treatment Drug Revenue, 2019-2030
6.3.2 US Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.3.3 Canada Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.3.4 Mexico Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Ulcerative Colitis Disease Treatment Drug Revenue, 2019-2030
6.4.2 Germany Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.4.3 France Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.4.4 U.K. Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.4.5 Italy Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.4.6 Russia Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.4.7 Nordic Countries Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.4.8 Benelux Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Ulcerative Colitis Disease Treatment Drug Revenue, 2019-2030
6.5.2 China Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.5.3 Japan Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.5.4 South Korea Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.5.5 Southeast Asia Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.5.6 India Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Ulcerative Colitis Disease Treatment Drug Revenue, 2019-2030
6.6.2 Brazil Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.6.3 Argentina Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ulcerative Colitis Disease Treatment Drug Revenue, 2019-2030
6.7.2 Turkey Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.7.3 Israel Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.7.4 Saudi Arabia Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
6.7.5 UAE Ulcerative Colitis Disease Treatment Drug Market Size, 2019-2030
7 Ulcerative Colitis Disease Treatment Drug Companies Profiles
7.1 Abbvie Inc.
7.1.1 Abbvie Inc. Company Summary
7.1.2 Abbvie Inc. Business Overview
7.1.3 Abbvie Inc. Ulcerative Colitis Disease Treatment Drug Major Product Offerings
7.1.4 Abbvie Inc. Ulcerative Colitis Disease Treatment Drug Revenue in Global Market (2019-2024)
7.1.5 Abbvie Inc. Key News & Latest Developments
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Company Summary
7.2.2 Bristol Myers Squibb Business Overview
7.2.3 Bristol Myers Squibb Ulcerative Colitis Disease Treatment Drug Major Product Offerings
7.2.4 Bristol Myers Squibb Ulcerative Colitis Disease Treatment Drug Revenue in Global Market (2019-2024)
7.2.5 Bristol Myers Squibb Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Ulcerative Colitis Disease Treatment Drug Major Product Offerings
7.3.4 Roche Ulcerative Colitis Disease Treatment Drug Revenue in Global Market (2019-2024)
7.3.5 Roche Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Ulcerative Colitis Disease Treatment Drug Major Product Offerings
7.4.4 Johnson & Johnson Ulcerative Colitis Disease Treatment Drug Revenue in Global Market (2019-2024)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Company Summary
7.5.2 Pfizer Inc. Business Overview
7.5.3 Pfizer Inc. Ulcerative Colitis Disease Treatment Drug Major Product Offerings
7.5.4 Pfizer Inc. Ulcerative Colitis Disease Treatment Drug Revenue in Global Market (2019-2024)
7.5.5 Pfizer Inc. Key News & Latest Developments
7.6 Prometheus Laboratories Inc. (Nestle)
7.6.1 Prometheus Laboratories Inc. (Nestle) Company Summary
7.6.2 Prometheus Laboratories Inc. (Nestle) Business Overview
7.6.3 Prometheus Laboratories Inc. (Nestle) Ulcerative Colitis Disease Treatment Drug Major Product Offerings
7.6.4 Prometheus Laboratories Inc. (Nestle) Ulcerative Colitis Disease Treatment Drug Revenue in Global Market (2019-2024)
7.6.5 Prometheus Laboratories Inc. (Nestle) Key News & Latest Developments
7.7 Bausch Health
7.7.1 Bausch Health Company Summary
7.7.2 Bausch Health Business Overview
7.7.3 Bausch Health Ulcerative Colitis Disease Treatment Drug Major Product Offerings
7.7.4 Bausch Health Ulcerative Colitis Disease Treatment Drug Revenue in Global Market (2019-2024)
7.7.5 Bausch Health Key News & Latest Developments
7.8 Takeda Pharmaceutical Ltd
7.8.1 Takeda Pharmaceutical Ltd Company Summary
7.8.2 Takeda Pharmaceutical Ltd Business Overview
7.8.3 Takeda Pharmaceutical Ltd Ulcerative Colitis Disease Treatment Drug Major Product Offerings
7.8.4 Takeda Pharmaceutical Ltd Ulcerative Colitis Disease Treatment Drug Revenue in Global Market (2019-2024)
7.8.5 Takeda Pharmaceutical Ltd Key News & Latest Developments
7.9 Biogen
7.9.1 Biogen Company Summary
7.9.2 Biogen Business Overview
7.9.3 Biogen Ulcerative Colitis Disease Treatment Drug Major Product Offerings
7.9.4 Biogen Ulcerative Colitis Disease Treatment Drug Revenue in Global Market (2019-2024)
7.9.5 Biogen Key News & Latest Developments
7.10 AstraZeneca
7.10.1 AstraZeneca Company Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Ulcerative Colitis Disease Treatment Drug Major Product Offerings
7.10.4 AstraZeneca Ulcerative Colitis Disease Treatment Drug Revenue in Global Market (2019-2024)
7.10.5 AstraZeneca Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ulcerative Colitis Disease Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Ulcerative Colitis Disease Treatment Drug Market Drivers in Global Market
Table 3. Ulcerative Colitis Disease Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Ulcerative Colitis Disease Treatment Drug in Global Market
Table 5. Top Ulcerative Colitis Disease Treatment Drug Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Ulcerative Colitis Disease Treatment Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Ulcerative Colitis Disease Treatment Drug Revenue Share by Companies, 2019-2024
Table 8. Global Companies Ulcerative Colitis Disease Treatment Drug Product Type
Table 9. List of Global Tier 1 Ulcerative Colitis Disease Treatment Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ulcerative Colitis Disease Treatment Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Ulcerative Colitis Disease Treatment Drug Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Ulcerative Colitis Disease Treatment Drug Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Ulcerative Colitis Disease Treatment Drug Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Ulcerative Colitis Disease Treatment Drug Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Ulcerative Colitis Disease Treatment Drug Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Ulcerative Colitis Disease Treatment Drug Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 30. Abbvie Inc. Company Summary
Table 31. Abbvie Inc. Ulcerative Colitis Disease Treatment Drug Product Offerings
Table 32. Abbvie Inc. Ulcerative Colitis Disease Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 33. Abbvie Inc. Key News & Latest Developments
Table 34. Bristol Myers Squibb Company Summary
Table 35. Bristol Myers Squibb Ulcerative Colitis Disease Treatment Drug Product Offerings
Table 36. Bristol Myers Squibb Ulcerative Colitis Disease Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 37. Bristol Myers Squibb Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Ulcerative Colitis Disease Treatment Drug Product Offerings
Table 40. Roche Ulcerative Colitis Disease Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 41. Roche Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Ulcerative Colitis Disease Treatment Drug Product Offerings
Table 44. Johnson & Johnson Ulcerative Colitis Disease Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Pfizer Inc. Company Summary
Table 47. Pfizer Inc. Ulcerative Colitis Disease Treatment Drug Product Offerings
Table 48. Pfizer Inc. Ulcerative Colitis Disease Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 49. Pfizer Inc. Key News & Latest Developments
Table 50. Prometheus Laboratories Inc. (Nestle) Company Summary
Table 51. Prometheus Laboratories Inc. (Nestle) Ulcerative Colitis Disease Treatment Drug Product Offerings
Table 52. Prometheus Laboratories Inc. (Nestle) Ulcerative Colitis Disease Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 53. Prometheus Laboratories Inc. (Nestle) Key News & Latest Developments
Table 54. Bausch Health Company Summary
Table 55. Bausch Health Ulcerative Colitis Disease Treatment Drug Product Offerings
Table 56. Bausch Health Ulcerative Colitis Disease Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 57. Bausch Health Key News & Latest Developments
Table 58. Takeda Pharmaceutical Ltd Company Summary
Table 59. Takeda Pharmaceutical Ltd Ulcerative Colitis Disease Treatment Drug Product Offerings
Table 60. Takeda Pharmaceutical Ltd Ulcerative Colitis Disease Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 61. Takeda Pharmaceutical Ltd Key News & Latest Developments
Table 62. Biogen Company Summary
Table 63. Biogen Ulcerative Colitis Disease Treatment Drug Product Offerings
Table 64. Biogen Ulcerative Colitis Disease Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 65. Biogen Key News & Latest Developments
Table 66. AstraZeneca Company Summary
Table 67. AstraZeneca Ulcerative Colitis Disease Treatment Drug Product Offerings
Table 68. AstraZeneca Ulcerative Colitis Disease Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 69. AstraZeneca Key News & Latest Developments
List of Figures
Figure 1. Ulcerative Colitis Disease Treatment Drug Segment by Type in 2023
Figure 2. Ulcerative Colitis Disease Treatment Drug Segment by Application in 2023
Figure 3. Global Ulcerative Colitis Disease Treatment Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Ulcerative Colitis Disease Treatment Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Ulcerative Colitis Disease Treatment Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ulcerative Colitis Disease Treatment Drug Revenue in 2023
Figure 8. By Type - Global Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
Figure 9. By Application - Global Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
Figure 10. By Type - Global Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
Figure 12. By Application - Global Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
Figure 14. By Region - Global Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
Figure 15. By Country - North America Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
Figure 16. US Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
Figure 20. Germany Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 21. France Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
Figure 28. China Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 32. India Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
Figure 34. Brazil Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Ulcerative Colitis Disease Treatment Drug Revenue Market Share, 2019-2030
Figure 37. Turkey Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Ulcerative Colitis Disease Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 41. Abbvie Inc. Ulcerative Colitis Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Bristol Myers Squibb Ulcerative Colitis Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Roche Ulcerative Colitis Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Johnson & Johnson Ulcerative Colitis Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Pfizer Inc. Ulcerative Colitis Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Prometheus Laboratories Inc. (Nestle) Ulcerative Colitis Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Bausch Health Ulcerative Colitis Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Takeda Pharmaceutical Ltd Ulcerative Colitis Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Biogen Ulcerative Colitis Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. AstraZeneca Ulcerative Colitis Disease Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
